Characterization of G6PD genotypes in G6PD deficiency patients from Suratthani Hospital, Thailand
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is highly prevalent in Southeast Asia especially in the area of malaria endemic regions. Primaquine is used for the radical treatment of malaria.
Suwannee Jitueakul +4 more
doaj
No G6PD A- (G202A) variant detected among <i>Plasmodium falciparum</i>-positive patients in Awka, Southeast Nigeria: a hospital-based study. [PDF]
Ikegbunam M +10 more
europepmc +1 more source
Characterisation of malaria and glucose-6-phosphate dehydrogenase deficiency in conflict-affected zones of southern and eastern Sudan. [PDF]
Jebreel WMA +11 more
europepmc +1 more source
Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity. [PDF]
Yee MEM +14 more
europepmc +1 more source
NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions. [PDF]
Radyk MD +22 more
europepmc +1 more source
G6PD variants but not Filipino beta-thalassemia are associated with reduced risk of Plasmodium knowlesi infection in Sabah, Malaysia. [PDF]
Nuin NA +5 more
europepmc +1 more source
Performance evaluation of an automated method for accurate identification of glucose-6-phosphate dehydrogenase deficiency on the BS-2800M analyzer. [PDF]
Liu Q, Xu A, Huang Y, Wang F.
europepmc +1 more source
Monogenic Syndromes as a Cause of Adverse Drug Reactions in the Russian Population. [PDF]
Buianova AA +9 more
europepmc +1 more source
Reduced cyclin D3 expression in erythroid cells protects against malaria. [PDF]
Marini MG +30 more
europepmc +1 more source
G6PD deficiency as a underrecognized genetic risk factor for rare neurological disorders: evidence from a population-based genetic analysis. [PDF]
Peng Q +6 more
europepmc +1 more source

